129 related articles for article (PubMed ID: 30481901)
21. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging.
Enzinger C; Strasser-Fuchs S; Ropele S; Kapeller P; Kleinert R; Fazekas F
Mult Scler; 2005 Apr; 11(2):135-9. PubMed ID: 15794384
[TBL] [Abstract][Full Text] [Related]
22. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
[TBL] [Abstract][Full Text] [Related]
23. [MRI features of cerebral parenchymal tuberculosis and the dynamic evolution during antituberculous treatment].
He W; Ning F; Zhou X; Lyu Y; Lyu P; Zhou Z; Li C; Wang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2015 Nov; 38(11):821-7. PubMed ID: 26850770
[TBL] [Abstract][Full Text] [Related]
24. [The clinical features, neuroimaging findings and pathological characteristics of 26 patients with pathologically proven tumor-like inflammatory demyelinating diseases].
Qi XK; Liu JG; Qian HR; Qiu F; Yao S; Li CQ; Wang YM
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):750-3. PubMed ID: 21092444
[TBL] [Abstract][Full Text] [Related]
25. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
26. Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study.
Chew SH; Achmad Sankala HB; Chew E; Md Arif MHB; Mohd Zain NR; Hashim H; Koya Kutty SB; Chee YC; Mohd Saleh NB; Ong BH; Viswanathan S
Mult Scler Relat Disord; 2023 Nov; 79():104992. PubMed ID: 37717306
[TBL] [Abstract][Full Text] [Related]
27. Imaging of Fulminant Demyelinating Disorders of the Central Nervous System.
Razek AAKA; Elsebaie NA
J Comput Assist Tomogr; 2020; 44(2):248-254. PubMed ID: 32195804
[TBL] [Abstract][Full Text] [Related]
28. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
Yiu EM; Laughlin S; Verhey LH; Banwell BL;
J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
[TBL] [Abstract][Full Text] [Related]
29. Tumefactive demyelinating brain lesions with multiple closed-ring enhancement in the course of neuromyelitis optica.
Tomizawa Y; Nakamura R; Hoshino Y; Sasaki F; Nakajima S; Kawajiri S; Noda K; Takanashi M; Fujita N; Yokoyama K; Hattori N; Takahashi T; Okuma Y
J Neurol Sci; 2016 Feb; 361():49-51. PubMed ID: 26810516
[No Abstract] [Full Text] [Related]
30. Tumefactive demyelinating lesions: nine cases and a review of the literature.
Xia L; Lin S; Wang ZC; Li SW; Xu L; Wu J; Hao SY; Gao CC
Neurosurg Rev; 2009 Apr; 32(2):171-9; discussion 179. PubMed ID: 19172322
[TBL] [Abstract][Full Text] [Related]
31. Tumefactive Demyelinating Lesions and Pregnancy.
Plantone D; Piantadosi C; Ruggieri S; Anelli V; Koudriavtseva T
Neurol India; 2019; 67(6):1519-1521. PubMed ID: 31857550
[TBL] [Abstract][Full Text] [Related]
32. Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Totaro R; Di Carmine C; Splendiani A; Torlone S; Patriarca L; Carrocci C; Sciamanna S; Marini C; Carolei A
Neurol Sci; 2016 Jul; 37(7):1113-7. PubMed ID: 27083895
[TBL] [Abstract][Full Text] [Related]
33. Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Di Gregorio M; Torri Clerici VLA; Fenu G; Gaetani L; Gallo A; Cavalla P; Ragonese P; Annovazzi P; Gajofatto A; Prosperini L; Landi D; Nicoletti CG; Di Carmine C; Totaro R; Nociti V; De Fino C; Ferraro D; Tomassini V; Tortorella C; Righini I; Amato MP; Manni A; Paolicelli D; Iaffaldano P; Lanzillo R; Moccia M; Buttari F; Fantozzi R; Cerqua R; Zagaglia S; Farina D; De Luca G; Buscarinu MC; Pinardi F; Cocco E; Gasperini C; Solaro CM; Di Filippo M
Eur J Neurol; 2021 Apr; 28(4):1299-1307. PubMed ID: 33305459
[TBL] [Abstract][Full Text] [Related]
34. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
[TBL] [Abstract][Full Text] [Related]
35. Demyelination preceding a diagnosis of central nervous system lymphoma.
Kalus S; Di Muzio B; Gaillard F
J Clin Neurosci; 2016 Feb; 24():146-8. PubMed ID: 26455545
[TBL] [Abstract][Full Text] [Related]
36. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
37. Tumefactive demyelinating lesion: experience with two unusual patients.
Sinha MK; Garg RK; Bhatt ML; Chandra A
J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
[TBL] [Abstract][Full Text] [Related]
38. Liver Transplant Recipient With Tumefactive Demyelinating Lesions: A Case Report and Literature Review.
Wan DL; Ren KW; Zhang LL; Wang B; Zhai ZL; Zhang XY; Yang YC; Zheng SS
Transplant Proc; 2016 Nov; 48(9):3197-3202. PubMed ID: 27932180
[TBL] [Abstract][Full Text] [Related]
39. Open ring enhancement in atypical brain demyelination.
Javalkar V; Manix M; Wilson J; Nanda A
J Clin Neurosci; 2012 Jun; 19(6):910-2. PubMed ID: 22342238
[TBL] [Abstract][Full Text] [Related]
40. Detailed magnetic resonance imaging features of a case series of primary gliosarcoma.
Sampaio L; Linhares P; Fonseca J
Neuroradiol J; 2017 Dec; 30(6):546-553. PubMed ID: 28644110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
